Skip to content

Effect of the Active Cycle of Breathing Technique on Coronary Artery Bypass Graft Patients' Outcomes

Effect of the Active Cycle of Breathing Technique on Coronary Artery Bypass Graft Patients' Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06910020
Enrollment
92
Registered
2025-04-04
Start date
2024-01-10
Completion date
2025-05-25
Last updated
2025-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass, Coronary Arterial Disease (CAD)

Keywords

CABG, ACBT, Postoperative Pulmonary Complications, Chest tube duration, Hemodynamic parameters, Chest expansion

Brief summary

Following CABG surgery, patients are at risk for several complications. One of the most common complications is postoperative pulmonary complications, which include atelectasis and dyspnea. These complications cause prolonged ICU length of stay and increased health care costs. Several studies recommended the active cycle of breathing technique as a method that increases secretion removal and improves lung functions, thus reducing the incidence of postoperative pulmonary complications. Our study aims to investigate the effect of the active cycle of breathing technique on coronary artery bypass graft patients' outcomes.

Interventions

* Patients will assume the sitting position and relax their shoulders, then perform the following: 1. Breathing control (abdominal breathing) 2. Chest expansion (thoracic breathing) 3. Huff cough (forced expiratory technique) * After completing the above actions, patients will be asked to cough up the residual deep sputum to promote pulmonary expansion. * The ACBT intervention will be performed for three days, each day two sessions, each session three courses, with 10 minutes of rest between them as needed.

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any adult patient who will undergo CABG

Exclusion criteria

* Mechanically ventilated patients on the first postoperative day. * Patients with preoperative lung collapse or pleural effusion.

Design outcomes

Primary

MeasureTime frameDescription
AtelectasisThe first three postoperative daysAtelectasis will be assessed using chest X-rays.
DyspneaThe first three postoperative daysDyspnea level will be assessed using the modified Borg scale.
Functional capacityThe first three postoperative daysFunctional capacity will be assessed using the six-minute walk test
Hemodynamic parametersThe first three postoperative daysHemodynamic parameters will include respiratory rate expressed as the number of cycles per minute, which will be assessed using the cardiac monitor
Chest expansionThe first three postoperative daysChest expansion will be measured at three points (axillary, xiphoid point, and umbilical level) using a measuring tape in centimeters.
Duration of chest tubeUp to 1 weekDuration of chest tube
Length of ICU stayFor up to 1 weekMeasure the duration of the patient's ICU stay
Hemodynamic ParametersFor the first three postoperative daysHemodynamic parameters will include oxygen saturation, which will be assessed using the pulse oximeter and will be expressed as a percentage %

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026